Moderna to launch trials of new booster vaccine that targets South African Covid variant

The Boston-based biotech has already shipped the raw materials to the US National Institutes of Health, which helped the firm study its first jab, to start human trials.

from Health News | Mail Online https://ift.tt/3pOkpYF